DMRA · Damora Therapeutics, Inc.

$29.99 -3.00 (-9.09%) At close · Jul 22

Market Cap

$1.85B

61.55M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hans T. Schambye	CEO	$547,521	$678,594	—	$73,677	—	—	$1,299,792
General Counsel	—	$400,400	$400,400	—	$26,955	—	$27,000	$854,755
Lori Firmani	CFO	$311,249	$202,500	—	$22,463	—	$27,000	$563,211

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hans T. Schambye	CEO	$526,084	$303,156	$142,000	$258,879	—	$199,431	$1,429,550
General Counsel	—	$400,400	$192,192	$71,000	$91,576	—	$142,200	$897,368
Garrett Winslow	General Counsel	$400,400	$192,192	$71,000	$91,576	—	$142,200	$897,368
Jonathan Freve	CFO	$328,182	—	$71,000	—	—	$420,572	$819,754
Lori Firmani	CFO	$261,188	$90,000	$39,050	$76,314	—	$95,340	$561,892

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hans T. Schambye	CEO	$505,741	$181,600	—	$277,774	—	—	$965,115
Bertil Lindmark	Chief Medical Officer	$335,808	—	—	$20,259	—	$463,551	$819,618
Jonathan Freve	CFO	$458,640	$110,100	—	$106,789	—	$25,800	$701,329
General Counsel	—	$385,000	$69,300	—	$74,288	—	$25,800	$554,388
Garrett Winslow	General Counsel	$385,000	$69,300	—	$74,288	—	$25,800	$554,388

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hans T. Schambye	CEO	$473,182	$226,953	—	$694,682	—	—	$1,394,817
Jonathan Freve	CFO	$441,506	$141,120	—	$284,187	—	$22,300	$889,113
Bertil Lindmark	Chief Medical Officer	$417,260	$110,804	—	$286,934	—	—	$814,998

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hans T. Schambye	CEO	$512,214	$222,982	—	$2,211,808	—	—	$2,947,004
Jonathan Freve	CFO	$420,000	$161,000	—	$912,491	—	$21,400	$1,514,891
Anders Pedersen	COO	$420,055	$120,340	—	$961,656	—	—	$1,502,051

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hans T. Schambye	CEO	$387,493	$257,489	—	$3,258,557	—	—	$3,903,539
Anders Pedersen	COO	$292,136	$157,523	—	$641,514	—	—	$1,091,173
Bertil Lindmark	Chief Medical Officer	$378,772	$189,386	—	$244,771	—	—	$812,929

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Hans T. Schambye	CEO	$360,000	$119,000	—	—	—	—	$479,000
Anders Pedersen	COO	$270,000	$85,000	—	—	—	—	$355,000

Executive changes

Person	Role	Change	Effective	Filed
Brian Burkavage	principal financial officer and principal accounting officer	Appointed	2026-05-01	2026-05-04

Key facts CIK 1800315 CUSIP 36322Q206 13F (30d) 3 filings 3 filers Visit website Investor relations